Physician profile
Mckenzie Decker
NPI 1245801141
$509.86
in general payments reported to CMS, 2019-2025
14 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.76 · 2022: $21.84 · 2023: $16.14 · 2024: $142 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $84.76 | 2021 | |
| Xeris Pharmaceuticals, INC. | $66.53 | 2025 | Recorlev |
| Medtronic, INC. | $57.46 | 2024 | Corevalve Evolut R, Symplicity G3 |
| Novo Nordisk INC | $48.32 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Boston Scientific Corporation | $47.57 | 2024-2025 | General - Pain Management |
| Abbvie INC. | $38.86 | 2022-2025 | |
| Amgen INC. | $32.85 | 2025 | Repatha, Otezla |
| Dexcom, INC. | $26.02 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $21.75 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $20.83 | 2024 | |
| Viatris Specialty LLC | $19.40 | 2025 | Yupelri |
| Pfizer INC. | $16.14 | 2023 | |
| Lilly USA, LLC | $15.34 | 2024 | Mounjaro |
| Axsome Therapeutics, INC. | $14.03 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mckenzie Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.